Blood collection devices are medical tools and consumables used for collecting blood samples from the patients for diagnostic and treatment purposes. Key blood collection products include needles, lancets, vials, vacutainers, blood bags and other sampling accessories. They find widespread applications in hospitals, diagnostic centers, blood banks and home healthcare settings. Blood collection devices offer safe, sterile and efficient blood drawing with minimal pain and discomfort to patients. The growing geriatric population, rising prevalence of target diseases like cancer, diabetes and cardiovascular diseases as well as increasing demand for blood and its components have augmented the need for blood collection globally.
The Global Blood Collection Devices Market is estimated to be valued at US$ 9,244.72 Mn in 2024 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the Blood Collection Devices are Becton Dickinson and Co, Terumo Corp, Cardinal Health Inc, SARSTEDT AG & Co KG, Nipro Corp, Thermo Fisher Scientific Inc, Sekisui Chemical Co Ltd, Greiner Bio-One International GmbH, FL Medical SRL, and IntervacTechnology OU.
The demand for blood collection devices is increasing rapidly owing to the growing volume of diagnostic tests,rising number of surgical procedures and the increasing prevalence of target diseases like cancer and diabetes requiring long term treatment and monitoring.
Technological advancements in blood collection technologies like Vacuette vacutainer blood collection tubes, evacuated blood collection tubes, safety-engineered blood collection needles and specialized blood collection sets are enhancing ease of use, sterility, safety and sample quality.
Market Trends
Some of the prominent trends in the blood collection devices market include growing popularity of needle-free blood collection systems to reduce healthcare associated infections and needlestick injuries. Manufacturers are also developing microbiology blood collection vials and blood collection devices integrated with traceability solutions to improve sample identification, tracking and management.
Market Opportunities
The rising geriatric population prone to chronic illnesses will augment the demand for long term treatment monitoring requiring frequent blood collection creating new opportunities. Home healthcare and self-monitoring is another emerging avenue for blood collection device makers to leverage.
Impact of COVID-19 on Blood Collection Devices Market Growth
The COVID-19 pandemic significantly impacted the growth of the blood collection devices market globally. During the initial phase of the pandemic, elective surgeries and non-essential procedures were postponed or cancelled to prioritize the treatment of COVID-19 patients and avoid increased exposure. This led to a decline in demand for blood collection procedures temporarily. However, the demand increased substantially for blood collection to perform testing for COVID-19 diagnosis as well as collecting convalescent plasma from recovered patients.
Fastest Growing Region for Blood Collection Devices Market
Asia Pacific is projected to witness the fastest growth over the forecast period attributed to rapidly expanding healthcare facilities, increasing investments by leading manufacturers, and rising incidence of chronic diseases necessitating diagnostic blood tests in highly populated countries such as India and China. Furthermore, growing awareness, improving access and affordability, and favorable government initiatives are expected to boost demand from other emerging economies in the region.
